Bomber,
I think we're still paying the price for two words on page 2 in the last quarterly
and
one paragraph in the RCH trial results.
Hopefully, they can be addressed soon. In the interim it's so frustrating.
Plus good luck dealing with Governments and their collective decision making as per the article in my previous post. It seems like Govts are still very reluctant to upset the big pathology players, even whilst the virus rips.
- Forums
- ASX - By Stock
- Ann: Rhinoswab junior clinical trial results
Bomber,I think we're still paying the price for two words on...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online